NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 20, 2026 3:59:58 PM EDT
39.34USD+2.395%(+0.92)9,122,260
Pre-marketOct 20, 2026 9:29:30 AM EDT
38.91USD+1.275%(+0.49)
After-hoursOct 20, 2026 4:54:30 PM EDT
39.27USD-0.178%(-0.07)
Loading…
Loading…
173.55B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$38.42
Beta
1.03
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$42.53
SMA 200
$45.00
Avg. Vol 10D
10.92M
Avg. Vol 30D
13.43M
Avg. Vol 90D
12.29M
Relative Vol
0.58
4.41B
3.17B
71.90%
31,622,458
1.00%
1.74
54%/46%
39.34%
18.33%
0.3400%
10,000,000
192
7,421
22,844
Nov 4, 2026 (14d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 21, 2026
Latest Wellness ETF Supplement: Peptides · 
The Daily Upside
Oct 20, 2026
Novo's CagriSema leads to 25% weight loss in women · 
Seeking Alpha
Hims & Hers gains after German launch · Seeking Alpha
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.06 | 2026-10-13 | +3.32% | 0.794 |
| 1M | 39.80 | 2026-09-21 | -1.19% | 0.751 |
| 3M | 49.61 | 2026-07-20 | -20.73% | -0.334 |
| 6M | 40.46 | 2026-04-20 | -2.81% | 0.122 |
| 1Y | 55.74 | 2025-10-20 | -29.45% | 1.028 |
| 2Y | 117.33 | 2024-10-21 | -66.48% | — |
| 5Y | 52.28 | 2021-10-20 | -24.77% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.33, and today's volume is 7,844,079. NVO is up 2.356% today. The 30 day average volume is 13.43M. NVO market cap is $173.55B with 4.41B shares outstanding.